Innovit — GUDID Connector / UDI Connector vs Salsify — GUDID publishing capability

GUDID HL7 SPL Submission Tools Comparison (2025)

Updated: December 2025

Choose Innovit — GUDID Connector / UDI Connector if...

HL7 SPL route with validation playground for UDI data Generates HL7 SPL. Validation tools available.

Choose Salsify — GUDID publishing capability if...

Data platform route for managing FDA GS1 UDI label requirements

Side-by-Side Comparison

Feature Innovit — GUDID Connector / UDI Connector Salsify — GUDID publishing capability
Route Direct HL7 SPL / ESG Submitter GDSN / Data Pool route
Best for HL7 SPL route with validation playground for UDI data Data platform route for managing FDA GS1 UDI label requirements
Generates HL7 SPL Not stated publicly
Handles ESG submission Not stated publicly Not stated publicly
Validation / QA tools Not stated publicly
Pricing Quote-based Quote-based

Choosing the right route

If you submit high volumes or need automated updates, HL7 SPL via ESG is typically required. Lower‑volume teams may start with the web app and migrate later. If you also need UDI strategy or regulatory support, explore the Cruxi directories hub.

FAQ

What are the two ways to submit data to GUDID?

FDA provides two submission paths: (1) Manual entry via the GUDID web app for low-volume submissions, and (2) HL7 SPL XML file submission via the FDA Electronic Submissions Gateway (ESG) for bulk/higher-volume submissions.

When should I use HL7 SPL instead of the web app?

Use HL7 SPL via ESG for higher-volume or bulk submissions, when you need automated workflows, or when integrating with existing UDI data management systems.

References